


TregTherapeutics Revenue
Biotechnology Research • Chapel Hill, North Carolina, United States • 1-10 Employees
TregTherapeutics revenue & valuation
| Annual revenue | $342,220 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,100,000 |
| Total funding | $250,000 |
Key Contact at TregTherapeutics
Russell Bromley
President
Company overview
| Headquarters | Chapel Hill, North Carolina, United States |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Founded | 2018 |
| Employees | 1-10 |
| Socials |
TregTherapeutics Email Formats
TregTherapeutics uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@tregtherapeutics.com), used 66.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@tregtherapeutics.com | 66.7% |
{first initial}{last name} | jdoe@tregtherapeutics.com | 33.3% |
About TregTherapeutics
TregTherapeutics Inc. is a preclinical stage company focused on the treatment and cure of multiple sclerosis. The objective of the TregTherapeutics tolerogenic vaccine is to reverse the inflammatory T cell immune attack in demyelinating lesions of an MS patient, and subsequently, to create an anti-inflammatory tolerogenic response within that patient.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
TregTherapeutics Tech Stack
Discover the technologies and tools that power TregTherapeutics's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Security
Miscellaneous
JavaScript libraries
JavaScript libraries
CDN
Font scripts
JavaScript libraries
Miscellaneous
Security
Programming languages
Frequently asked questions
4.8
40,000 users



